GeneDx Holdings Corp. (WGS)

GeneDx Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	427.54	305.45	202.57	234.69	212.2
Revenue Growth (YoY)	39.97%	50.79%	-13.69%	10.60%	18.33%
Cost of Revenue	129.37	111.05	112.56	261.44	228.8
Gross Profit	298.17	194.4	90.01	-26.75	-16.6
Selling, General & Admin	239.22	171.89	199.98	338.24	318.73
Research & Development	72.03	45.72	58.27	86.2	105.16
Other Operating Expenses	-	-	12.36	216.46	5.66
Total Operating Expenses	311.25	217.61	270.6	640.9	429.55
Operating Income	-13.08	-23.21	-180.6	-667.65	-446.15
Interest Income	-	-	-	-	0.08
Interest Expense	-	-	-	-	-2.84
Other Non-Operating Income (Expense)	-8.06	-29.42	3.9	69.62	203.52
Total Non-Operating Income (Expense)	-8.06	-29.42	3.9	69.62	200.76
Pretax Income	-21.14	-52.63	-176.69	-598.03	-245.39
Provision for Income Taxes	-0.12	-0.34	-0.93	-49.05	-
Net Income	-21.02	-52.29	-175.77	-548.98	-245.39
Net Income to Common	-21.02	-52.29	-175.77	-548.98	-245.39
Shares Outstanding (Basic)	29	27	24	10	3
Shares Outstanding (Diluted)	29	27	24	10	3
Shares Change (YoY)	6.51%	10.61%	137.50%	212.56%	2106262.09%
EPS (Basic)	-0.73	-1.94	-7.23	-53.63	-74.91
EPS (Diluted)	-0.73	-1.94	-7.23	-53.63	-74.91
Free Cash Flow	14.26	-33.99	-185.4	-326.31	-199.83
Free Cash Flow Per Share	0.50	-1.26	-7.63	-	-61.02
Gross Margin	69.74%	63.64%	44.43%	-11.40%	-7.82%
Operating Margin	-3.06%	-7.60%	-89.15%	-284.48%	-210.25%
Profit Margin	-4.92%	-17.12%	-86.77%	-233.91%	-115.64%
FCF Margin	3.34%	-11.13%	-91.52%	-139.04%	-94.17%
EBITDA	12.15	-1.26	-146.86	-608.34	-424.34
EBITDA Margin	2.84%	-0.41%	-72.50%	-259.21%	-199.98%
EBIT	-13.08	-23.21	-180.6	-667.65	-446.15
EBIT Margin	-3.06%	-7.60%	-89.15%	-284.48%	-210.25%
Effective Tax Rate	0.55%	0.65%	0.52%	8.20%	0.00%

Updated Feb 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q